News

20th April 2023 – Upperton Increases Oral Dosage Form Capabilities at its Nottingham HQ

by

20th April 2023 – Upperton Increases Oral Dosage Form Capabilities at its Nottingham HQ Nottingham, UK, 20th April: Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK. Part of Upperton’s £15m investment program announced in January this … Read more

Newsletter – December 21st 2022

by

NEWSLETTER: Seasons Greetings To All Of Our Customers Traditionally at this time of year we like to offer Season’s Greetings to all our customers and friends and whilst doing so, look back over the years at some of the highlights in what has been an exceptionally busy (and successful) year for Upperton Pharma Solutions! Here … Read more

29th November 2022 Upperton Pharma Solutions Appoints T-SQUARED for Design and Build of New Development and Manufacturing Facility

by

29th November 2022 – Upperton Pharma Solutions Appoints T-SQUARED for Design and Build of New Development and Manufacturing Facility Upperton Pharma Solutions Appoints T-SQUARED for Design and Build of New Development and Manufacturing Facility Upperton Pharma Solutions, a leading UK contract development and manufacturing organisation (CDMO), is delighted to announce that it has appointed T-SQUARED, … Read more

Newsletter – November 16th 2022

by

Upperton Launches ASAPprime® Shelf-Life Stability Testing Upperton has made a significant investment in ASAPprime® software and hardware to enable the company to offer its clients state of the art stability testing. This exciting new platform can be used to generate robust, accelerated chemical stability data and is now being applied at all stages of the … Read more

20th May 2021 – Upperton Nasal Delivery Article Published in ONdrugDelivery

by

Article 20th May 2021 – Upperton Nasal Delivery Article Published in ONdrugDelivery Formulation Options In Nasal Drug Delivery Upperton had an article published in Edition 119 ONdrugDeliver in May 2021 In the article Richard Johnson, CEO and founder of Upperton,  discusses the advantages of nasal delivery and why there is growing interest in this route … Read more

29th April 2021 – Formulation Options in Nasal Drug Delivery

by

News 29th April 2021 – Formulation Options in Nasal Drug Delivery Nasal delivery offers a number of unique opportunities for the successful delivery of drugs and vaccines either locally, systemically or directly to the central nervous system. This utility has resulted in growing interest from scientists looking to administer both therapeutic agents and vaccines via … Read more

25th March 2021 – Formulation Options in Nasal Drug Delivery

by

News 25th March 2021 – Formulation Options in Nasal Drug Delivery The anatomy and physiology of the nasal cavity creates a number of unique opportunities for the successful delivery of drugs and vaccines. This can be locally, systemically or directly to the central nervous system. This utility has resulted in growing interest from scientists looking to … Read more

15th December 2020 – Season’s Greetings

by

News 15th December 2020 – Season’s Greetings and End of Year Review Season’s Greetings and a Happy New Year to all of our Customers and our industry contacts from everyone at Upperton Pharma Solutions! Once again, we head towards the year-end holiday break with the Upperton team continuing to work at full capacity to ensure … Read more

1st December 2020 – Manufacturing Clinical Supplies: The Early Phase Clinical Manufacture Timeline

by

News 1st December 2020 – Manufacturing Clinical Supplies: The Early Phase Clinical Manufacture Timeline Whilst undergoing research and development on a new chemical entity / new biological entity there are major initial objectives when planning the roadmap to clinic, submission and approval of the regulatory documentation, and ultimately dosage form administration in a human clinical … Read more

Upperton Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.

Quick Links

Contact Us

Albert Einstein Centre, Nottingham Science Park, Nottingham, UK NG7 2TN,
Phone: +44 (0) 115 855 7050
Email: contact@upperton.com